Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Debopam Samanta

Concepts (343)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Epilepsy
33
2026
190
14.200
Why?
Anticonvulsants
21
2026
134
8.680
Why?
Seizures
24
2025
203
5.950
Why?
Spasms, Infantile
12
2026
32
4.890
Why?
Tuberous Sclerosis
8
2025
38
4.080
Why?
Cannabidiol
8
2025
44
3.780
Why?
Status Epilepticus
6
2021
33
3.130
Why?
Epilepsies, Myoclonic
5
2024
15
2.900
Why?
Mutation
16
2023
1338
2.890
Why?
Electroencephalography
20
2026
309
2.770
Why?
Humans
123
2026
53246
2.710
Why?
Deep Brain Stimulation
4
2025
42
2.660
Why?
Child
46
2026
7384
2.320
Why?
Intellectual Disability
5
2023
129
2.060
Why?
Brain
10
2024
1353
1.990
Why?
Hemiplegia
3
2021
12
1.880
Why?
Infant
26
2026
3808
1.750
Why?
Developmental Disabilities
5
2019
127
1.580
Why?
Epilepsy, Absence
3
2019
11
1.530
Why?
Magnetic Resonance Imaging
16
2025
1587
1.520
Why?
Child, Preschool
24
2026
4164
1.400
Why?
Genetic Therapy
2
2025
127
1.400
Why?
Algorithms
2
2025
668
1.330
Why?
Tumor Suppressor Proteins
3
2023
130
1.310
Why?
Neuroaxonal Dystrophies
2
2022
8
1.310
Why?
Nervous System Malformations
3
2020
17
1.300
Why?
Folate Receptor 1
2
2022
27
1.270
Why?
Infant, Newborn, Diseases
2
2020
56
1.200
Why?
Epilepsies, Partial
2
2022
15
1.190
Why?
Ketamine
2
2020
62
1.180
Why?
Vagus Nerve Stimulation
2
2025
15
1.090
Why?
Neurocutaneous Syndromes
2
2019
6
1.070
Why?
Delayed Diagnosis
2
2026
30
1.060
Why?
Cadherins
2
2019
62
1.050
Why?
Male
41
2026
27444
1.040
Why?
Female
37
2026
28792
1.020
Why?
Treatment Outcome
14
2026
5597
1.010
Why?
Cerebral Arteries
2
2019
35
0.990
Why?
Epilepsy, Generalized
2
2023
9
0.970
Why?
ras GTPase-Activating Proteins
1
2026
1
0.970
Why?
Vigabatrin
3
2024
3
0.960
Why?
Sirolimus
2
2017
72
0.950
Why?
Tic Disorders
1
2026
4
0.940
Why?
Neurosurgical Procedures
3
2026
137
0.930
Why?
Angiofibroma
2
2015
5
0.920
Why?
Facial Neoplasms
2
2015
22
0.910
Why?
Nerve Tissue Proteins
2
2018
193
0.900
Why?
Adolescent
19
2026
6912
0.890
Why?
Valproic Acid
2
2022
35
0.880
Why?
Stroke
3
2019
520
0.850
Why?
Fenfluramine
2
2024
7
0.840
Why?
Dioxolanes
2
2024
16
0.830
Why?
Randomized Controlled Trials as Topic
2
2024
630
0.830
Why?
Thalamus
1
2024
33
0.830
Why?
Pregnanolone
2
2023
6
0.810
Why?
Landau-Kleffner Syndrome
1
2022
3
0.760
Why?
Quality Improvement
2
2022
230
0.730
Why?
Aphasia
1
2022
37
0.720
Why?
Nervous System Diseases
2
2021
93
0.710
Why?
Abnormalities, Multiple
3
2023
166
0.700
Why?
Chromosome Deletion
3
2019
138
0.700
Why?
Phenotype
3
2026
803
0.690
Why?
Emergencies
1
2021
78
0.670
Why?
Pharmaceutical Preparations
1
2021
74
0.670
Why?
Angelman Syndrome
1
2020
1
0.650
Why?
Transition to Adult Care
1
2020
24
0.640
Why?
Bone Diseases, Developmental
2
2023
17
0.630
Why?
Tooth Abnormalities
2
2023
13
0.630
Why?
Immunoglobulins, Intravenous
1
2021
64
0.630
Why?
Oligonucleotides, Antisense
1
2020
29
0.620
Why?
Phenobarbital
1
2020
17
0.620
Why?
Immunologic Factors
1
2021
117
0.620
Why?
Flunarizine
1
2019
1
0.610
Why?
Behavioral Symptoms
1
2019
4
0.610
Why?
Excitatory Amino Acid Antagonists
1
2020
46
0.610
Why?
Ocular Physiological Phenomena
1
2019
3
0.600
Why?
Tetrasomy
1
2019
2
0.600
Why?
Agenesis of Corpus Callosum
2
2018
11
0.600
Why?
Chromosomes, Human, Pair 5
1
2019
17
0.600
Why?
Sneddon Syndrome
1
2019
3
0.590
Why?
Livedo Reticularis
1
2019
5
0.590
Why?
Calcium Channel Blockers
1
2019
57
0.590
Why?
Oral Ulcer
1
2019
3
0.590
Why?
Behcet Syndrome
1
2019
7
0.590
Why?
Transposases
1
2019
11
0.580
Why?
Andersen Syndrome
1
2019
1
0.580
Why?
Spinal Cord Diseases
1
2019
39
0.580
Why?
Hydrocephalus
1
2019
46
0.580
Why?
Receptors, GABA-B
1
2019
10
0.580
Why?
Vitiligo
1
2019
8
0.580
Why?
Autoimmune Diseases of the Nervous System
1
2019
9
0.570
Why?
Leukoencephalopathies
1
2019
15
0.570
Why?
Cytochrome-c Oxidase Deficiency
1
2018
3
0.570
Why?
Edema
1
2019
64
0.570
Why?
Migraine Disorders
2
2020
48
0.570
Why?
Physicians
1
2022
242
0.570
Why?
Cerebral Infarction
1
2018
37
0.570
Why?
Electron Transport Complex IV
1
2018
24
0.570
Why?
Optic Atrophy
1
2018
13
0.560
Why?
Muscle Weakness
1
2019
46
0.560
Why?
Nephrotic Syndrome
2
2017
35
0.560
Why?
Cannabinoid Receptor Agonists
1
2019
50
0.560
Why?
Diffuse Cerebral Sclerosis of Schilder
1
2018
8
0.560
Why?
Photic Stimulation
1
2018
56
0.560
Why?
Alopecia
1
2019
38
0.560
Why?
Amino Acyl-tRNA Synthetases
1
2018
7
0.560
Why?
Shab Potassium Channels
1
2018
2
0.560
Why?
Brain Edema
1
2018
40
0.550
Why?
Parents
1
2021
341
0.550
Why?
Thrombocytopenia
1
2019
89
0.540
Why?
Lymphohistiocytosis, Hemophagocytic
1
2018
31
0.540
Why?
Myoclonus
1
2018
9
0.540
Why?
Artifacts
1
2018
56
0.540
Why?
Autoimmune Diseases
1
2019
90
0.540
Why?
Biomedical Research
1
2021
267
0.540
Why?
Mitochondrial Diseases
1
2018
45
0.530
Why?
Practice Guidelines as Topic
1
2020
502
0.520
Why?
Neurodegenerative Diseases
1
2018
81
0.520
Why?
Models, Biological
1
2020
737
0.510
Why?
Hearing Loss, Sensorineural
1
2018
82
0.510
Why?
Osteochondrodysplasias
1
2017
14
0.510
Why?
Health Knowledge, Attitudes, Practice
1
2021
523
0.510
Why?
Immunologic Deficiency Syndromes
1
2017
18
0.510
Why?
Arteriosclerosis
1
2017
49
0.500
Why?
Infant, Newborn
6
2024
2913
0.500
Why?
Carotid Artery Diseases
1
2017
33
0.500
Why?
Drug Discovery
1
2017
94
0.490
Why?
Cafe-au-Lait Spots
1
2016
2
0.480
Why?
Child Development
1
2018
215
0.480
Why?
Skin
1
2019
420
0.470
Why?
Williams Syndrome
1
2016
25
0.470
Why?
Prenatal Exposure Delayed Effects
1
2018
214
0.470
Why?
Migraine with Aura
1
2015
4
0.470
Why?
Erythema Infectiosum
1
2015
3
0.470
Why?
Corpus Callosum
2
2023
28
0.470
Why?
Pulmonary Embolism
1
2017
83
0.470
Why?
Leukoencephalitis, Acute Hemorrhagic
1
2015
3
0.470
Why?
Syndrome
6
2024
248
0.470
Why?
Sinus Pericranii
1
2015
1
0.460
Why?
Parvovirus B19, Human
1
2015
16
0.460
Why?
Toes
1
2015
15
0.460
Why?
Electrodiagnosis
1
2015
13
0.460
Why?
SOS1 Protein
1
2015
2
0.460
Why?
Crying
1
2015
4
0.460
Why?
Moyamoya Disease
1
2015
7
0.460
Why?
Hyperventilation
1
2015
8
0.460
Why?
Iatrogenic Disease
1
2015
26
0.460
Why?
Tuberculoma
1
2015
1
0.460
Why?
Epilepsy, Benign Neonatal
1
2015
2
0.450
Why?
Noonan Syndrome
1
2015
12
0.450
Why?
Encephalitis
1
2016
40
0.450
Why?
Neurologic Examination
1
2015
75
0.450
Why?
Communication
3
2022
263
0.450
Why?
Ocular Motility Disorders
1
2015
16
0.450
Why?
Repressor Proteins
2
2023
149
0.450
Why?
Mutism
1
2015
3
0.450
Why?
NAV1.2 Voltage-Gated Sodium Channel
1
2015
3
0.450
Why?
Retrospective Studies
9
2026
6821
0.440
Why?
TOR Serine-Threonine Kinases
1
2015
83
0.440
Why?
Diagnosis, Differential
7
2020
1038
0.440
Why?
Trisomy
1
2014
34
0.430
Why?
Neurology
1
2015
33
0.430
Why?
Influenza, Human
1
2015
88
0.430
Why?
KCNQ2 Potassium Channel
1
2014
8
0.420
Why?
Energy Drinks
1
2014
6
0.420
Why?
Vasoconstriction
1
2014
55
0.420
Why?
Benzodiazepines
1
2014
72
0.410
Why?
Osteomyelitis
1
2015
134
0.410
Why?
Membrane Proteins
1
2016
333
0.400
Why?
Enzyme Inhibitors
1
2015
371
0.390
Why?
Sleep
1
2014
196
0.380
Why?
Palliative Care
2
2026
195
0.380
Why?
Quality of Life
4
2025
902
0.370
Why?
Magnetic Resonance Angiography
3
2019
72
0.370
Why?
Immunosuppressive Agents
3
2019
253
0.360
Why?
Consensus
2
2025
206
0.350
Why?
Pediatrics
1
2015
307
0.350
Why?
Receptors, N-Methyl-D-Aspartate
2
2022
79
0.330
Why?
Diffusion Magnetic Resonance Imaging
3
2017
133
0.310
Why?
Clinical Trials as Topic
2
2024
466
0.310
Why?
Caregivers
2
2021
247
0.290
Why?
Recurrence
3
2019
694
0.290
Why?
Echinocandins
1
2008
64
0.280
Why?
Mycoses
1
2008
152
0.260
Why?
Gastroesophageal Reflux
2
2019
51
0.250
Why?
Antifungal Agents
1
2008
350
0.230
Why?
Administration, Topical
2
2015
62
0.230
Why?
Adult
6
2025
14541
0.220
Why?
Prospective Studies
3
2026
2412
0.220
Why?
Seizures, Febrile
1
2024
3
0.220
Why?
Meta-Analysis as Topic
1
2024
40
0.220
Why?
Magnetoencephalography
1
2025
89
0.210
Why?
Memory, Short-Term
1
2025
74
0.210
Why?
Neuropsychological Tests
1
2026
345
0.210
Why?
Intralaminar Thalamic Nuclei
1
2024
6
0.210
Why?
Animals
4
2026
13528
0.210
Why?
Psychosurgery
1
2023
5
0.200
Why?
Databases, Factual
2
2024
742
0.200
Why?
Comorbidity
1
2026
638
0.200
Why?
Laser Therapy
1
2023
75
0.190
Why?
Speech Disorders
1
2022
16
0.190
Why?
Ethosuximide
1
2022
5
0.190
Why?
Clonazepam
1
2022
6
0.190
Why?
Cluster Analysis
1
2023
238
0.180
Why?
Electrodes, Implanted
1
2022
36
0.180
Why?
Stereotaxic Techniques
1
2022
41
0.180
Why?
Death, Sudden
1
2022
9
0.180
Why?
GTPase-Activating Proteins
1
2022
25
0.180
Why?
Concept Formation
1
2021
13
0.180
Why?
Perivascular Epithelioid Cell Neoplasms
1
2021
4
0.170
Why?
Freedom
1
2021
3
0.170
Why?
Folic Acid
1
2022
137
0.170
Why?
Diazepam
1
2021
18
0.170
Why?
Drug Interactions
1
2022
196
0.170
Why?
Fibroma
1
2021
41
0.170
Why?
Adrenocorticotropic Hormone
2
2022
32
0.170
Why?
Personal Satisfaction
1
2021
76
0.160
Why?
Risk Factors
2
2020
4018
0.160
Why?
Soft Tissue Neoplasms
1
2021
62
0.160
Why?
Brain Diseases
1
2021
85
0.160
Why?
Dihydroergotamine
1
2020
5
0.160
Why?
Transcription Factors
2
2023
571
0.160
Why?
Perception
1
2021
124
0.160
Why?
Mental Disorders
1
2025
446
0.160
Why?
Facies
2
2023
36
0.160
Why?
Diet Therapy
1
2020
8
0.160
Why?
Genetic Diseases, Inborn
1
2020
23
0.160
Why?
Clinical Protocols
1
2020
109
0.150
Why?
Treatment Failure
1
2020
119
0.150
Why?
Anesthetics
1
2020
38
0.150
Why?
Learning
1
2021
156
0.150
Why?
Leukomalacia, Periventricular
1
2019
12
0.150
Why?
Muscle Hypotonia
1
2019
23
0.150
Why?
Chromosomes, Human, Pair 7
1
2019
29
0.150
Why?
Matrix Attachment Region Binding Proteins
1
2020
38
0.150
Why?
HLA-B51 Antigen
1
2019
2
0.150
Why?
Analgesics, Non-Narcotic
1
2020
120
0.150
Why?
Ventriculoperitoneal Shunt
1
2019
29
0.150
Why?
Patient-Centered Care
1
2021
141
0.150
Why?
Craniofacial Abnormalities
1
2019
27
0.150
Why?
Ubiquitin-Protein Ligases
1
2020
140
0.150
Why?
Qualitative Research
1
2021
384
0.150
Why?
Heart Septal Defects, Atrial
1
2019
45
0.150
Why?
Disease Management
1
2020
187
0.150
Why?
Potassium Channels, Inwardly Rectifying
1
2019
7
0.150
Why?
Ventricular Premature Complexes
1
2019
7
0.150
Why?
Microcephaly
1
2019
40
0.140
Why?
Melkersson-Rosenthal Syndrome
1
2018
4
0.140
Why?
Facial Nerve Diseases
1
2018
6
0.140
Why?
Referral and Consultation
1
2021
299
0.140
Why?
Syncope
1
2019
31
0.140
Why?
Nocturnal Myoclonus Syndrome
1
2018
13
0.140
Why?
Cerebral Veins
1
2018
17
0.140
Why?
Facial Paralysis
1
2018
25
0.140
Why?
Deglutition Disorders
1
2019
76
0.140
Why?
Anti-Arrhythmia Agents
1
2019
79
0.140
Why?
Health Personnel
1
2021
259
0.140
Why?
Fatal Outcome
1
2019
193
0.140
Why?
Acute Disease
1
2019
393
0.140
Why?
Fibrinolytic Agents
1
2019
132
0.140
Why?
Frameshift Mutation
1
2018
18
0.140
Why?
Video Recording
1
2018
81
0.140
Why?
Combined Modality Therapy
1
2020
640
0.140
Why?
Anti-Inflammatory Agents
1
2019
164
0.130
Why?
Fear
1
2018
85
0.130
Why?
Cerebellum
1
2018
121
0.130
Why?
India
1
2017
59
0.130
Why?
History, 21st Century
1
2017
60
0.130
Why?
Platelet Aggregation Inhibitors
1
2019
213
0.130
Why?
History, 20th Century
1
2017
97
0.130
Why?
Neurotoxicity Syndromes
1
2017
46
0.130
Why?
Methotrexate
1
2017
78
0.130
Why?
Pandemics
1
2021
595
0.120
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2017
92
0.120
Why?
Anti-Infective Agents
1
2017
107
0.120
Why?
Aldehyde Dehydrogenase
1
2016
24
0.120
Why?
Influenza B virus
1
2015
6
0.120
Why?
Hormones
1
2016
58
0.120
Why?
Chromosomes, Human, Pair 3
1
2015
18
0.120
Why?
Arkansas
1
2021
2068
0.120
Why?
North America
1
2015
75
0.110
Why?
Cerebral Angiography
1
2015
94
0.110
Why?
Complementary Therapies
1
2015
23
0.110
Why?
Antibiotics, Antineoplastic
1
2015
84
0.110
Why?
Chromosomes, Human, Pair 9
1
2014
20
0.110
Why?
Brain Waves
1
2014
19
0.110
Why?
Drug Resistance
1
2015
71
0.110
Why?
Polymerase Chain Reaction
1
2015
452
0.100
Why?
Antiemetics
1
2014
32
0.100
Why?
Headache
1
2014
75
0.100
Why?
Glutamine
1
2015
177
0.100
Why?
Vomiting
1
2014
71
0.100
Why?
Mutation, Missense
1
2014
110
0.100
Why?
Arginine
1
2015
178
0.100
Why?
Analgesics
1
2014
104
0.100
Why?
Decision Making, Computer-Assisted
1
2013
3
0.100
Why?
Diagnostic Errors
1
2013
68
0.090
Why?
Evidence-Based Medicine
1
2013
275
0.090
Why?
Inflammation
1
2016
653
0.090
Why?
Pregnancy
1
2018
2610
0.080
Why?
Signal Transduction
1
2017
1748
0.080
Why?
Antineoplastic Agents
1
2017
1232
0.070
Why?
Dysentery
1
2009
1
0.070
Why?
Trichuriasis
1
2009
1
0.070
Why?
Trichuris
1
2009
1
0.070
Why?
Anesthesia, Intravenous
1
2008
12
0.070
Why?
Eosinophils
1
2009
40
0.070
Why?
Lipopeptides
1
2008
62
0.070
Why?
Amyloidosis
1
2009
83
0.070
Why?
Tuberculosis
1
2009
133
0.070
Why?
Candidiasis
1
2008
114
0.070
Why?
Aspergillosis
1
2008
122
0.070
Why?
Inflammatory Bowel Diseases
1
2009
89
0.060
Why?
Kidney Diseases
1
2009
230
0.060
Why?
Clinical Trials, Phase III as Topic
1
2025
48
0.060
Why?
Observer Variation
1
2024
138
0.050
Why?
Spasm
1
2024
9
0.050
Why?
Feedback
1
2024
53
0.050
Why?
Kaplan-Meier Estimate
1
2025
487
0.050
Why?
Probability
1
2023
171
0.050
Why?
Neuroimaging
1
2023
95
0.050
Why?
Young Adult
2
2025
4514
0.050
Why?
Pilot Projects
1
2025
727
0.050
Why?
Cohort Studies
1
2026
1557
0.040
Why?
Potassium Channels
1
2021
32
0.040
Why?
Reproducibility of Results
1
2024
1221
0.040
Why?
Registries
1
2024
652
0.040
Why?
Administration, Intravenous
1
2020
73
0.040
Why?
Sleep Stages
1
2020
42
0.040
Why?
Age of Onset
1
2020
109
0.040
Why?
Cognition
1
2022
346
0.040
Why?
Follow-Up Studies
1
2025
2318
0.040
Why?
Immunohistochemistry
1
2021
975
0.040
Why?
Aged
1
2025
10430
0.020
Why?
Software
1
2013
280
0.020
Why?
Internet
1
2013
265
0.020
Why?
Middle Aged
1
2025
13422
0.020
Why?
Mebendazole
1
2009
2
0.020
Why?
Antinematodal Agents
1
2009
3
0.020
Why?
Leukemoid Reaction
1
2009
6
0.020
Why?
Antitubercular Agents
1
2009
89
0.020
Why?
Colonoscopy
1
2009
107
0.020
Why?
Prognosis
1
2009
2118
0.010
Why?
Samanta's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description